NIH won't cut price of taxpayer-funded prostate cancer drug - Medical Xpress

STAT

NIH won't cut price of taxpayer-funded prostate cancer drug Medical Xpress The federal government has declined a petition to lower the price of a prostate cancer drug developed with taxpayer money. The public interest group Knowledge Ecology International petitioned the National Institutes of Health in January to reduce the ... U.S. NIH refused petition to override prostate cancer drug patentPulse Headlines NIH rejects petition to override patent on pricey prostate cancer drugSTAT all 6 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFaGdEELUi_PhyT7oQsmR8aVMmbiA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779136313558&ei=wA5pV4gnjs3eAcrqrrgI&url=http://medicalxpress.com/news/2016-06-nih-wont-price-taxpayer-funded-prostate.html
via IFTTT